Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × eribulin × Clear all

Phase

Phase 2 65 Phase 1 14 Phase 1/2 9 Phase 3 8 Phase EARLY_PHASE1 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

INDUSTRY 2 OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Dexamethasone 49 Metformin 47 Cyclophosphamide 42 Saline Solution 38 Cytarabine 34 Sodium Chloride 31 Bupivacaine 31 Vincristine 27 Propofol 25 Methotrexate 25 Cisplatin 25 Letrozole 24 Fluorouracil 24 Dexmedetomidine 24 Doxorubicin 23 Fentanyl 22 Carboplatin 22 Etoposide 19 Rituximab 18 Morphine 18 Acetaminophen 18 Lidocaine 17 Granulocyte Colony-Stimulating Factor 17 Bevacizumab 17 Prednisone 16 Mercaptopurine 16 Docetaxel 16 Clomiphene 16 Sevoflurane 15 Ropivacaine 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05033769 2023-04-18

AIRE

Institut fuer Frauengesundheit

Phase 4 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡